Medicare Enrolled

Dr. Ihab Deebajah, MD

Pulmonary Disease · Garden City, MI
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Speaking/Promotional
6255 INKSTER RD, Garden City, MI 48135
7345240950
In practice since 2006 (20 years)
NPI: 1205807260 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Deebajah from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Deebajah? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Deebajah

Dr. Ihab Deebajah is a pulmonary disease specialist in Garden City, MI, with 20 years of NPI registration. Based on federal Medicare data, Dr. Deebajah performed 3,362 Medicare services across 2,252 unique beneficiaries.

Between the years covered by Open Payments, Dr. Deebajah received a total of $169,165 from 27 pharmaceutical and/or device companies across 307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in pulmonary disease. The majority of payments are for speaking programs and promotional activities, reflecting participation in industry-sponsored events. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Deebajah is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ Top 5% volume in MI $169,165 industry payments

Medicare Practice Summary

Medicare Utilization ↗
3,362
Medicare services
Top 5% in MI for pulmonary disease
2,252
Unique beneficiaries
$78
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~168 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
833 $103 $140
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
523 $66 $100
Smoking cessation counseling, more than 10 minutes
Intensive counseling session focused on helping patients quit smoking and tobacco use, lasting more than 10 minutes.
216 $29 $50
Spirometry test before and after medication
A test that measures the amount of air you can exhale and the speed of your breathing before and after taking a medication.
212 $30 $150
Lung volume test using gas dilution or washout
A test that measures the amount of air in your lungs by using a gas dilution or washout method.
212 $35 $100
Pulmonary gas exchange test
A test to examine how well the lungs exchange gases.
212 $45 $140
Expiratory airflow and volume test
A test that measures the amount of air you can exhale and the speed at which you can breathe it out. It evaluates lung function by assessing expiratory airflow and volume.
149 $22 $65
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
142 $133 $200
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
141 $66 $120
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
135 $144 $280
Exercise-induced lung stress test
A test performed to evaluate how the lungs function during physical exertion. It helps identify breathing difficulties or lung conditions that occur specifically when exercising.
123 $27 $80
Chest X-ray, 2 views
An X-ray imaging test of the chest that captures two different angles to visualize the lungs, heart, and chest wall.
120 $27 $50
Breathing device use evaluation
An assessment of how a patient uses a breathing device. The provider reviews the patient's technique and device handling.
85 $14 $50
Drug injection, under skin or into muscle
A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle.
51 $12 $35
Sleep study with continuous airway pressure, age 6+
A sleep study conducted in a sleep lab that monitors breathing and other body functions while administering continuous airway pressure. This test is performed on patients aged 6 years or older.
50 $510 $1,000
Sleep study in sleep lab (age 6+)
An overnight test conducted in a sleep laboratory to monitor sleep patterns and bodily functions in patients aged 6 years or older.
35 $492 $1,000
Hospital follow-up visit, high complexity
Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter.
30 $99 $170
Telephone medical discussion, 11-20 minutes
A phone conversation with a physician lasting between 11 and 20 minutes.
29 $60 $100
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
27 $148 $200
Lung volume test using sensors
A test that measures the amount of air in the lungs using sensors.
20 $10 $41
Sleep study with heart rate and breathing monitoring
A sleep study that monitors heart rate, breathing, airflow, and physical effort during sleep.
17 $74 $300
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$169,165
Total received (2018-2024)
Avg $24,166/year across 7 years
Top 2% in MI for pulmonary disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
27
Companies
307
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$167,099 (98.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,067 (1.2%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$47,421
2023
$41,869
2022
$24,249
2021
$29,528
2020
$5,011
2019
$20,763
2018
$325

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
GlaxoSmithKline, LLC.
$27,169
AstraZeneca Pharmaceuticals LP
$19,709
Regeneron Healthcare Solutions, Inc.
$181
SANOFI-AVENTIS U.S. LLC
$100
GENZYME CORPORATION
$67
Mylan Specialty L.P.
$48
Inspire Medical Systems, Inc.
$43
Takeda Pharmaceuticals U.S.A., Inc.
$36
Boehringer Ingelheim Pharmaceuticals, Inc.
$30
Optinose US, Inc.
$21
ANI Pharmaceuticals, Inc.
$17
Top 3 companies account for 99.2% of 2024 payments
All-time payments by company (2018-2024) ›
GlaxoSmithKline, LLC.
$114,722
AstraZeneca Pharmaceuticals LP
$46,925
Boehringer Ingelheim Pharmaceuticals, Inc.
$4,369
ViiV Healthcare Company
$1,600
Mylan Specialty L.P.
$433
Regeneron Healthcare Solutions, Inc.
$305
Abbott Laboratories
$162
SANOFI-AVENTIS U.S. LLC
$100
GENZYME CORPORATION
$67
Takeda Pharmaceuticals U.S.A., Inc.
$59
Inspire Medical Systems, Inc.
$43
HARMONY BIOSCIENCES LLC
$42
Merck Sharp & Dohme Corporation
$37
Janssen Pharmaceuticals, Inc
$35
Mallinckrodt Enterprises LLC
$30
Circassia Pharmaceuticals Inc
$30
Pulmonx Corporation
$27
JAZZ PHARMACEUTICALS INC.
$26
Optinose US, Inc.
$21
Jazz Pharmaceuticals Inc.
$20
Sunovion Pharmaceuticals Inc.
$19
ANI Pharmaceuticals, Inc.
$17
Advanced Respiratory, Inc
$17
Nabriva Therapeutics, plc
$16
Resmed Corp
$14
Merck Sharp & Dohme LLC
$14
Insmed, Inc.
$14
Top 3 companies account for 98.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · AIRSENSE · AIRSUPRA · ANORO · ANORO ELLIPTA · AREXVY · Arikayce · BEVESPI AEROSPHERE · BREO · BREZTRI · CHARTIS CATHETER · DUAKLIR PRESSAIR · DUPIXENT · Dragonfly OCT · FASENRA · GLASSIA · INSPIRE · LONHALA MAGNAIR · NUCALA · OFEV · PURIFIED CORTROPHIN GEL · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · TRELEGY ELLIPTA · The Vest System Model 105 Home Care · Wakix · XARELTO · Xenleta · Xhance · YUPELRI · Yupelri · ZERBAXA
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (99%) are for speaking programs and promotional activities, which reflect participation in industry-sponsored educational or marketing events. This is common in pulmonary disease and does not inherently indicate bias, but patients may wish to be aware. Total industry engagement is in the top 2% for pulmonary disease in MI.

Looking for a pulmonary disease specialist in Garden City?
Compare pulmonary diseases in the Garden City area by procedure volume, costs, and industry payment transparency.
Browse pulmonary diseases nearby

Geographic Context

Pulmonary diseases within 10 mi
102
Per 100K population
5.8
County median income
$59,521
Nearest hospital
GARDEN CITY HOSPITAL
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Deebajah is a clinical cardiology specialist, with above-average Medicare volume (top 5% in MI), with speaking/promotional industry engagement in the top 2% of MI peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Deebajah experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Deebajah performed 833 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Deebajah receive payments from pharmaceutical companies?
Yes. Dr. Deebajah received a total of $169,165 from 27 companies across 307 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Deebajah's costs compare to other pulmonary diseases in Garden City?
Dr. Deebajah's average Medicare payment per service is $78. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Deebajah) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →